Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2010 May 25;19(6):1484–1491. doi: 10.1158/1055-9965.EPI-10-0030

Table 1.

Distribution of selected characteristics of the patient cohort (n =1,286)

Variable Total SPM-Free SPM P-valuesc


No. % No. % No. %
Total patients 1,286 100 1,166 90.7 120 9.3
Age
 ≤ median (57 years) 665 51.7 626 53.7 39 32.5 <.0001
 > median (57 years) 621 48.3 540 46.3 81 67.5
Sex
 Male 977 76.0 883 75.7 94 78.3 0.525
 Female 309 24.0 283 24.3 26 21.7
Ethnicity
 Non-Hispanic White 1,087 84.5 993 85.2 94 78.3 0.050
 Other 199 15.5 173 14.8 26 21.7
Smoking
 Never 343 26.7 318 27.3 25 20.8 0.129
 Ever 943 73.3 848 72.7 95 79.2
Alcohol
 Never 335 26.1 308 26.4 27 22.5 0.352
 Ever 951 73.9 858 73.6 93 77.5
Index Cancer Site
 Oral cavity 417 32.4 379 32.5 38 31.7 0.322
 Oropharynx 573 44.6 525 45.0 48 40.0
 Larynx/Hypopharynx 296 23.0 262 22.5 34 28.3
Index Cancer Stage
 I or II 323 25.1 291 25.0 32 26.7 0.681
 III or IV 963 74.9 875 75.0 88 73.3
Treatment
 Surgery only 229 17.8 208 17.8 21 17.5 0.889
 Surgery + Adjuvant Txa 320 24.9 287 24.6 33 27.5
 XRTb 329 25.6 301 25.8 28 23.3
 XRT + Chemotherapy 408 31.7 370 31.7 38 31.7
a

Adjuvant Treatment: adjuvant radiotherapy and/or chemotherapy

b

XRT: radiotherapy

c

P values were calculated from chi-square test